financetom
Business
financetom
/
Business
/
Canon to launch surveillance systems, broadcasting cameras, remote printing systems, says CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canon to launch surveillance systems, broadcasting cameras, remote printing systems, says CEO
Apr 15, 2023 9:25 AM

Canon India has launched a new live office in Mumbai which the company claims will improve customer experience. The development comes as a part of Canon’s 2023 growth strategy which aims for transformation across domains.

Speaking to CNBC-TV18 the company's president and CEO Manabu Yamazaki said, "Live office is a showroom where people are working. So we have a display of our entire line-up of flagship products so that people understand what we do. Mumbai is our first launch and will be soon replicated in Kolkata and other locations."

Yamazaki added that the company is planning to get into surveillance systems, broadcasting cameras, and remote printing systems categories.

"Canon has successfully evolved into a solution-level company. So we would like to take this further by stretching our product offerings. We plan to get into surveillance systems, broadcasting cameras, remote printing systems, so those are the new categories that we are looking to introduce," Yamazaki said.

Also read: Coca Cola investing in key passion points for their sparkling brands

Also, Bala Sarda, founder of Vahdam spoke about the brand's journey so far and their plan going ahead. Vahdam is India’s leading and fastest-growing home-grown wellness brand which has marked its presence across the globe.

Moreover, Arijeet Talapatra, CEO of Tecno Mobile India discussed the company’s plans for making an entry into the ultra-premium segment of smartphones with its latest offering the Phantom V Fold. Actor Ayushmann Khurrana also spoke about his association with the brand Tecno.

Watch the accompanying video for more.

First Published:Apr 15, 2023 6:25 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blueprint Medicines Insider Sold Shares Worth $576,223, According to a Recent SEC Filing
Blueprint Medicines Insider Sold Shares Worth $576,223, According to a Recent SEC Filing
Mar 7, 2025
04:22 PM EST, 03/07/2025 (MT Newswires) -- Fouad Namouni, President, R&D, on March 05, 2025, sold 6,489 shares in Blueprint Medicines ( BPMC ) for $576,223. Following the Form 4 filing with the SEC, Namouni has control over a total of 75,781 common shares of the company, with 75,781 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1597264/000141588925007402/xslF345X05/form4-03072025_090326.xml ...
Xylem Insider Sold Shares Worth $527,978, According to a Recent SEC Filing
Xylem Insider Sold Shares Worth $527,978, According to a Recent SEC Filing
Mar 7, 2025
04:19 PM EST, 03/07/2025 (MT Newswires) -- Geri-Michelle McShane, Vice President, Controller & Chief Accounting Officer, on March 07, 2025, sold 4,119 shares in Xylem (XYL) for $527,978. Following the Form 4 filing with the SEC, McShane has control over a total of 3,950 common shares of the company, with 3,950 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1524472/000156218025002198/xslF345X05/primarydocument.xml ...
Blueprint Medicines Insider Sold Shares Worth $576,756, According to a Recent SEC Filing
Blueprint Medicines Insider Sold Shares Worth $576,756, According to a Recent SEC Filing
Mar 7, 2025
04:20 PM EST, 03/07/2025 (MT Newswires) -- Christina Rossi, COO, on March 05, 2025, sold 6,495 shares in Blueprint Medicines ( BPMC ) for $576,756. Following the Form 4 filing with the SEC, Rossi has control over a total of 71,540 common shares of the company, with 71,540 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1597264/000141588925007404/xslF345X05/form4-03072025_090313.xml ...
Blueprint Medicines Insider Sold Shares Worth $467,266, According to a Recent SEC Filing
Blueprint Medicines Insider Sold Shares Worth $467,266, According to a Recent SEC Filing
Mar 7, 2025
04:23 PM EST, 03/07/2025 (MT Newswires) -- Tracey L McCain, Chief Legal Officer and Executive Vice President, on March 05, 2025, sold 5,262 shares in Blueprint Medicines ( BPMC ) for $467,266. Following the Form 4 filing with the SEC, McCain has control over a total of 66,583 common shares of the company, with 66,583 shares held directly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved